Cargando…
Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate Tumors
Background: Despite a growing number of studies evaluating cancer of prostate (CaP) specific gene alterations, oncogenic activation of the ETS Related Gene (ERG) by gene fusions remains the most validated cancer gene alteration in CaP. Prevalent gene fusions have been described between the ERG gene...
Autores principales: | Dubovenko, Alexey, Serebryiskaya, Tatiana, Nikolsky, Yuri, Nikolskaya, Tatiana, Perlina, Ally, JeBailey, Lellean, Bureeva, Svetlana, Katta, Shilpa, Srivastava, Shiv, Dobi, Albert, Khasanova, Tatiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439933/ https://www.ncbi.nlm.nih.gov/pubmed/26000039 http://dx.doi.org/10.7150/jca.8213 |
Ejemplares similares
-
Knowledge-based analysis of proteomics data
por: Bessarabova, Marina, et al.
Publicado: (2012) -
Oncogenic activation of ERG: A predominant mechanism in prostate cancer
por: Sreenath, Taduru L, et al.
Publicado: (2011) -
Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer
por: Thangapazham, Rajesh, et al.
Publicado: (2014) -
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
por: Furusato, B, et al.
Publicado: (2010) -
Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer
por: Xiao, Qingyu, et al.
Publicado: (2018)